Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Atorvastatin calcium suspension - CMP Pharma

Next Previous
Drug Profile

Atorvastatin calcium suspension - CMP Pharma

Alternative Names: ATORVALIQ; Atorvastatin calcium oral suspension - CMP Pharma

Latest Information Update: 27 Jun 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator CMP Pharma
  • Class Amides; Antihyperlipidaemics; Esters; Fatty acids; Fluorobenzenes; Heptanoic acids; Pyrroles; Small molecules
  • Mechanism of Action HMG-CoA reductase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Coronary disorders; Hyperlipidaemia; Hyperlipoproteinaemia type II; Hyperlipoproteinaemia type III; Hypertriglyceridaemia

Most Recent Events

  • 23 Jun 2023 Launched for Coronary disorders (Prevention) in USA (PO)
  • 23 Jun 2023 Launched for Hyperlipidaemia in USA (PO)
  • 23 Jun 2023 Launched for Hyperlipoproteinaemia type II (Adjunctive treatment, In adolescents, In children, In the elderly, In adults) in USA (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top